Möchten Sie immer auf dem neuesten Stand bleiben?

Kraig Biocraft Laboratories (OTCQB:KBLB) is attracting additional attention, as its spider silk technology is featured on the cover of National Geographic

Kraig Biocraft Labs (OTCQB: KBLB) groundbreaking work in commercializing spider silk is featured on the cover of the March 2026 issue of National Graphic

U.S. equity markets are pointing modestly lower this morning and any fresh Fed commentary, but today’s headlines are dominated by transformative stocks

Kraig Labs (OTCQB: KBLB) is entering its defining phase and accelerating toward commercial-scale production of biodegradable spider silk

Execution is the theme this morning, as a cluster of emerging growth stocks move from pilot programs and strategic roadmaps into operational scale.

Kraig Biocraft Laboratories (OTCQB: KBLB) announced that its 2026 production plan has officially moved from strategy to execution.

Kraig Labs (OTCQB: KBLB) is entering a new phase of commercial scale-up as it accelerates spider silk production to meet growing demand from global brands.

As AI continues to move beyond software and automation, its impact on genomics and gene editing is becoming increasingly tangible

Kraig Labs (OTCQB: KBLB) 2026 production plan will drive explosive growth and establish a new global benchmark for spider silk manufacturing.

Innovation still rules, but ownership of the entire supply-chain pipeline is becoming the next biggest strategic advantage in today’s markets.